Chromatin as a target antigen in human and murine lupus nephritis

被引:0
|
作者
Annica Hedberg
Elin S Mortensen
Ole P Rekvig
机构
[1] University of Tromsø,Molecular Pathology Research Group, Institute of Medical Biology, Faculty of Health Science
来源
Arthritis Research & Therapy | / 13卷
关键词
Systemic Lupus Erythematosus; Systemic Lupus Erythematosus Patient; Lupus Nephritis; Mesangial Matrix; Histone Chaperone;
D O I
暂无
中图分类号
学科分类号
摘要
The present review focuses on pathogenic molecular and transcriptional events in patients with lupus nephritis. These factors are renal DNaseI, exposed chromatin fragments and the corresponding chromatin-reactive autoantibodies. Lupus nephritis is the most serious complication in human systemic lupus erythematosus, and is characterised by deposition of chromatin fragment-IgG complexes in the mesangial matrix and glomerular basement membranes. The latter deposition defines end-stage disease. This event is stringently linked to a renal-restricted shutdown of expression of the DNaseI gene, as determined by loss of DNaseI mRNA level and DNaseI enzyme activity. The major aim of the present review is to generate new therapeutic strategies based on new insight into the disease pathogenesis.
引用
收藏
相关论文
共 50 条
  • [41] DEFECTIVE ANTIGEN PRESENTATION IN MURINE LUPUS
    FISCHBACH, M
    TALAL, N
    CLINICAL RESEARCH, 1982, 30 (05): : A874 - A874
  • [42] New immunosuppresor strategies in the treatment of murine lupus nephritis
    Alperovich, G.
    Rama, I.
    Lloberas, N.
    Franquesa, M.
    Poveda, R.
    Goma-i-Freixanet, M.
    Herrero-Fresneda, I.
    Cruzado, J. M.
    Bolanos, N.
    Carrera, M.
    Grinyo, J. M.
    Torras, J.
    LUPUS, 2007, 16 (01) : 18 - 24
  • [43] Chemokines and cytokines during the development of murine lupus nephritis
    Silveira, K.
    Simes e Silva, A. C.
    Teixeira, M.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1598 - 1598
  • [44] BIOMARKERS OF CRESCENTIC GLOMERULONEPHRITIS IN MURINE MODEL OF LUPUS NEPHRITIS
    Ka, Shuk-Man
    Cheng, Chao-Wen
    Tsai, Pei-Yi
    Luo, Yi-Fen
    Chen, Jan-Hen
    Lee, Herng-Sheng
    Chen, Ann
    NEPHROLOGY, 2005, 10 : A118 - A118
  • [45] MURINE LUPUS NEPHRITIS - A STRUCTURE-FUNCTION STUDY
    KIBERD, BA
    LABORATORY INVESTIGATION, 1991, 65 (01) : 51 - 60
  • [46] INCREASED RENAL THROMBOXANE PRODUCTION IN MURINE LUPUS NEPHRITIS
    KELLEY, VE
    SNEVE, S
    MUSINSKI, S
    JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (01): : 252 - 259
  • [47] NEPHRITOGENICITY OF ANTIPROTEOGLYCAN ANTIBODIES IN EXPERIMENTAL MURINE LUPUS NEPHRITIS
    KASHIHARA, N
    MAKINO, H
    SZEKANECZ, Z
    WALTENBAUGH, CR
    KANWAR, YS
    LABORATORY INVESTIGATION, 1992, 67 (06) : 752 - 760
  • [48] EFFECT OF CYCLOPHOSPHAMIDE (CY) ON IMMUNOREACTANTS OF MURINE LUPUS NEPHRITIS
    CAVALLO, T
    GRAVES, K
    GRANHOLM, NA
    KIDNEY INTERNATIONAL, 1984, 25 (01) : 221 - 221
  • [49] EFFECT OF IBUPROFEN, A PROSTAGLANDIN INHIBITOR, IN MURINE LUPUS NEPHRITIS
    KELLEY, VE
    IZUI, S
    KIDNEY INTERNATIONAL, 1982, 21 (01) : 200 - 200
  • [50] The role of aldosterone blockade in murine lupus nephritis.
    Monrad, Seetha
    Killen, Paul D.
    Bradke, Amanda
    Mehta, Hemal
    Kaplan, Mariana J.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4090 - 4090